Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELATE: Everolimus and Octreotide in Polycystic Liver Disease
NCT01157858Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of everolimus in Polycystic liver disease (PLD) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Liver volume at 12 months. Started Jun 2010; status: completed.
02
Drugs
everolimus
03
Conditions
Polycystic liver disease (PLD)
Beyond the preview
Go deeper on NCT01157858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01157858.